Michael R Gold

22PUBLICATIONS
66CO-AUTHORS
HaematologyCardiology (incl. cardiovascular diseases)Respiratory diseasesMedical devicesCircuits and systems
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (22)

|Aug 31, 2025
Cost-effectiveness of apixaban vs. aspirin for the reduction of thrombo-embolism in high-risk patients with device-detected atrial fibrillation: insights from the ARTESiA trial.

Andre Lamy, Roopinder K Sandhu, Wesley Tong

|Jul 31, 2024
Outcomes of Cardiac Resynchronization Therapy by New York Heart Association Class: A Patient-Level Meta-Analysis.

Nishkala Shivakumar, Daniel J Friedman, Marat Fudim

|Dec 28, 2023
Conventional biventricular pacing is still preferred to conduction system pacing for atrioventricular block in patients with reduced ejection fraction and narrow QRS.

Michael Glikson, Marek Jastrzebski, Michael R Gold

|Nov 06, 2023
Cardiac magnetic resonance-derived myocardial scar is associated with echocardiographic response and clinical prognosis of left bundle branch area pacing for cardiac resynchronization therapy.

Zhongli Chen, Xuan Ma, Yuan Gao

|Jul 31, 2023
Cardiac resynchronization therapy in patients with a prior history of atrial fibrillation: Insights from four major clinical trials.

Frederik Dalgaard, Marat Fudim, Sana M Al-Khatib

|May 15, 2023
Effects of Atrioventricular Optimization on Left Ventricular Reverse Remodeling With Cardiac Resynchronization Therapy: Results of the SMART-CRT Trial.

Michael R Gold, Kenneth A Ellenbogen, Christophe Leclercq

Pageof 4